{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T22:30:52Z","timestamp":1725057052802},"reference-count":36,"publisher":"Springer Publishing Company","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neonatal Network"],"published-print":{"date-parts":[[2021,7,1]]},"abstract":"<jats:p>Chronic pain and agitation can complicate the clinical course of critically ill infants. Randomized controlled trials of analgesia and sedation in neonatal intensive care have focused on relatively short durations of exposure. To date, clinicians have few options to treat chronic visceral pain and hyperalgesia. Gabapentin has emerged as a common therapy for a diverse group of pain syndromes and neurologic conditions in adults. In neonates, case reports and series describe the successful treatment of visceral hyperalgesia arising from gastrointestinal insults with or without concomitant neurologic morbidities. Additionally, a case report and series describe the utility of gabapentin for neonatal abstinence syndrome refractory to standard pharmacotherapy. The adverse effect profile of gabapentin, most notably bradycardia and sedation, compares favorably to alternative analgesics and sedatives. However, the long-term impacts of prolonged gabapentin therapy have not been studied. Therefore, candidates for therapy must be selected carefully, and response must be assessed objectively. Future studies must assess the short-term and long-term benefits and risks of gabapentin compared to standard therapies for chronic pain and agitation in infants and refractory neonatal abstinence syndrome.<\/jats:p>","DOI":"10.1891\/11-t-687","type":"journal-article","created":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T16:20:22Z","timestamp":1627662022000},"page":"267-272","source":"Crossref","is-referenced-by-count":2,"title":["Gabapentin in Infants: Critical Evaluation of a Novel Sedative\/Analgesic Medication"],"prefix":"10.1891","volume":"40","author":[{"given":"Christopher","family":"McPherson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"793","published-online":{"date-parts":[[2021,7,30]]},"reference":[{"key":"2021090210100922000_40.4.267.1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pedn.2018.10.004","article-title":"A systematic review of behavioral and environmental interventions for procedural pain management in preterm infants","volume":"44","year":"2019","journal-title":"J Pediatr Nurs"},{"key":"2021090210100922000_40.4.267.2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-4271"},{"issue":"2","key":"2021090210100922000_40.4.267.3","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41390-019-0744-6","article-title":"The influence of pain, agitation, and their management on the immature brain","volume":"88","year":"2020","journal-title":"Pediatr Res"},{"key":"2021090210100922000_40.4.267.4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jpeds.2016.07.001","article-title":"Sedation, analgesia, and paralysis during mechanical ventilation of premature infants","volume":"180","year":"2017","journal-title":"J Pediatr"},{"issue":"4","key":"2021090210100922000_40.4.267.5","first-page":"351","article-title":"Sedation and analgesia in mechanically ventilated preterm neonates: Continue standard of care or experiment?","volume":"17","year":"2012","journal-title":"J Pediatr Pharmacol Ther"},{"key":"2021090210100922000_40.4.267.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.clp.2013.10.002"},{"key":"2021090210100922000_40.4.267.7","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-3369"},{"key":"2021090210100922000_40.4.267.8","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200601000-00005"},{"key":"2021090210100922000_40.4.267.9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.22.2644"},{"key":"2021090210100922000_40.4.267.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2013.10.002"},{"key":"2021090210100922000_40.4.267.11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pediatrneurol.2019.02.012","article-title":"Gabapentin use for hospitalized neonates","volume":"97","year":"2019","journal-title":"Pediatr Neurol"},{"key":"2021090210100922000_40.4.267.12","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.50.6.682"},{"key":"2021090210100922000_40.4.267.13","doi-asserted-by":"publisher","DOI":"10.1111\/j.0013-9580.2004.06204.x"},{"issue":"8","key":"2021090210100922000_40.4.267.14","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/jama.2017.21897","article-title":"Gabapentin approvals, off-label use, and lessons for postmarketing evaluation efforts","volume":"319","year":"2018","journal-title":"JAMA"},{"key":"2021090210100922000_40.4.267.15","doi-asserted-by":"publisher","DOI":"10.1046\/j.0003-2409.2001.02399.x"},{"key":"2021090210100922000_40.4.267.16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1999.tb00804.x"},{"key":"2021090210100922000_40.4.267.17","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.5.982"},{"key":"2021090210100922000_40.4.267.18","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199912000-00006"},{"issue":"2","key":"2021090210100922000_40.4.267.19","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1001\/jamainternmed.2017.7856","article-title":"Gabapentinoid use in the United States 2002 through 2015","volume":"178","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"4","key":"2021090210100922000_40.4.267.20","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.pcl.2014.04.011","article-title":"Pediatric palliative care for children with complex chronic medical conditions","volume":"61","year":"2014","journal-title":"Pediatr Clin North Am"},{"issue":"3","key":"2021090210100922000_40.4.267.21","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/dmcn.14324","article-title":"Gabapentin for pain, movement disorders, and irritability in neonates and infants","volume":"62","year":"2020","journal-title":"Dev Med Child Neurol"},{"key":"2021090210100922000_40.4.267.22","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jpeds.2015.10.013","article-title":"Gabapentin use in the neonatal intensive care unit","volume":"169","year":"2016","journal-title":"J Pediatr"},{"issue":"4","key":"2021090210100922000_40.4.267.23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/jpm.2012.0103","article-title":"Treatment with gabapentin associated with resolution of apnea in two infants with neurologic impairment","volume":"16","year":"2013","journal-title":"J Palliat Med"},{"issue":"8","key":"2021090210100922000_40.4.267.24","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1592\/phco.29.8.997","article-title":"Gabapentin therapy for pain and irritability in a neurologically impaired infant","volume":"29","year":"2009","journal-title":"Pharmacotherapy"},{"issue":"1","key":"2021090210100922000_40.4.267.25","first-page":"59","article-title":"Gabapentin improves oral feeding in neurologically intact infants with abdominal disorders","volume":"23","year":"2018","journal-title":"J Pediatr Pharmacol Ther"},{"key":"2021090210100922000_40.4.267.26","doi-asserted-by":"crossref","unstructured":"Bruce AS , Davis AM , Baum CF , et al. Retrospective study of gabapentin for poor oral feeding in infants with congenital heart disease. Glob Pediatr Health . 2015;2:2333794X15591565. https:\/\/doi.org\/10.1177\/2333794X15591565","DOI":"10.1177\/2333794X15591565"},{"issue":"2","key":"2021090210100922000_40.4.267.27","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/jp.2014.154","article-title":"The neonatal pain, agitation and sedation scale and the bedside nurse's assessment of neonates","volume":"35","year":"2015","journal-title":"J Perinatol"},{"key":"2021090210100922000_40.4.267.28","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jp.7211861"},{"issue":"4","key":"2021090210100922000_40.4.267.29","doi-asserted-by":"crossref","first-page":"84","DOI":"10.9734\/IJMPCR\/2015\/16142","article-title":"Use of gabapentin as an adjunct agent in the treatment of neonatal abstinence syndrome: A case report","volume":"3","year":"2015","journal-title":"Int J Med Pharm Case Rep"},{"key":"2021090210100922000_40.4.267.30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1999.tb00921.x"},{"issue":"10","key":"2021090210100922000_40.4.267.31","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/j.1460-9592.2010.03396.x","article-title":"Gabapentin as part of multimodal analgesia in a newborn with epidermolysis bullosa","volume":"20","year":"2010","journal-title":"Paediatr Anaesth"},{"key":"2021090210100922000_40.4.267.32","doi-asserted-by":"publisher","DOI":"10.1542\/peds.108.2.482"},{"issue":"5","key":"2021090210100922000_40.4.267.33","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1177\/00912700122010384","article-title":"Single-dose gabapentin pharmacokinetics and safety in healthy infants and children","volume":"41","year":"2001","journal-title":"J Clin Pharmacol"},{"key":"2021090210100922000_40.4.267.34","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-1211(01)00311-4"},{"key":"2021090210100922000_40.4.267.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2015.09.007"},{"key":"2021090210100922000_40.4.267.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2015.06.023"}],"container-title":["Neonatal Network"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1891\/11-T-687","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T17:13:07Z","timestamp":1630602787000},"score":1,"resource":{"primary":{"URL":"http:\/\/connect.springerpub.com\/lookup\/doi\/10.1891\/11-T-687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,7,30]]},"published-print":{"date-parts":[[2021,7,1]]}},"alternative-id":["10.1891\/11-T-687"],"URL":"https:\/\/doi.org\/10.1891\/11-t-687","relation":{},"ISSN":["0730-0832","1539-2880"],"issn-type":[{"value":"0730-0832","type":"print"},{"value":"1539-2880","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,1]]}}}